nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

17.06.2022 | Epilepsy (C. Elder, Section Editor)

Suicide and Epilepsy

verfasst von: Luciana Giambarberi, Heidi M. Munger Clary

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Epilepsy has a bidirectional association with suicidality, and epilepsy patients are at much higher risk for suicide than the general population. This article reviews the recent literature on suicide risk factors, assessments, and management as they pertain specifically to suicidality in people with epilepsy, a population that requires unique considerations.

Recent Findings

Risk factors for suicidality include younger age (independent of comorbid psychiatric disorders), poor social support, psychiatric comorbidity (depression, anxiety, obsessive-compulsive symptoms, and alcohol use), and epilepsy-related factors (more frequent seizures, temporal lobe epilepsy, and drug-resistant epilepsy). Most clinicians agree with the need for addressing suicidality; however, there is inconsistency in the approach to caring for these patients. An example neurology clinic-based approach is outlined.

Summary

Although PWE are at risk for suicide and risk factors have been characterized, care gaps remain. Screening strategies may help close these gaps.

Bachmann S. Epidemiology of suicide and the psychiatric perspective. Int J Environ Res Public Health. 2018;15(7). https://doi.org/10.3390/ijerph15071425.

Prevention CfDCa. National Center for Injury Prevention and Control, WISQARS Fatal Injury Reports. Centers for Disease Control and Prevention. Facts About Suicide. 2022. https://www.cdc.gov/suicide/facts/. Accessed 8 June 2022.

Cramer RJ, Kaniuka AR, Yada FN, Diaz-Garelli F, Hill RM, Bowling J, et al. An analysis of suicidal thoughts and behaviors among transgender and gender diverse adults. Soc Psychiatry Psychiatr Epidemiol. 2021. https://doi.org/10.1007/s00127-021-02115-8.

Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer M, Beautrais A, Bruffaerts R, Chiu WT, De Girolamo G, Gluzman S, De Graaf R, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192:98–105.CrossRef

Laanani M, Imbaud C, Tuppin P, Poulalhon C, Jollant F, Coste J, et al. Contacts with health services during the year prior to suicide death and prevalent conditions: a nationwide study. J Affect Disord. 2020;274:174–82. https://doi.org/10.1016/j.jad.2020.05.071.CrossRefPubMed

Mekonen T, Getnet A, Belete A, Menberu M, Fekadu W. Suicidal behavior among people with epilepsy in Northwest Ethiopia: a comparative cross-sectional study. Epilepsy Behav. 2020;111:107233. https://doi.org/10.1016/j.yebeh.2020.107233.CrossRefPubMed

National Center for Chronic Disease Prevention and Health Promotion DoPH. Epilepsy Data and Statistics, Centers for Disease Control and Prevention. 2015. https://www.cdc.gov/epilepsy/data/index.html. Accessed 23 May 2021.

Organization TWH. The World Health Organization. Epilepsy. 2022. https://www.who.int/news-room/fact-sheets/detail/epilepsy. Accessed 8 June 2022.

Jones JE, Hermann BP, Barry JJ, Gilliam FG, Kanner AM, Meador KJ. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav. 2003;4(Suppl 3):S31–8. https://doi.org/10.1016/j.yebeh.2003.08.019.CrossRefPubMed

10.

Robertson MM. Suicide, parasuicide, and epilepsy. In: Tap JE, editor. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott–Raven; 1997.

11.

Hamed SA, Elserogy YB, Abdou MA, Abdellah MM. Risks of suicidality in adult patients with epilepsy. World J Psychiatry. 2012;2(2):33–42. https://doi.org/10.5498/wjp.v2.i2.33.CrossRefPubMedPubMedCentral

12.

Husari KS, Blackburn KM, Ding K, Roaten K, Hays R. Assessing recent suicidal ideation and behavior in the adult epilepsy monitoring unit. Epilepsy Behav. 2019;94:100–3. https://doi.org/10.1016/j.yebeh.2019.02.007.CrossRefPubMed

13.

Hecimovic H, Santos JM, Carter J, Attarian HP, Fessler AJ, Vahle V, et al. Depression but not seizure factors or quality of life predicts suicidality in epilepsy. Epilepsy Behav. 2012;24(4):426–9. https://doi.org/10.1016/j.yebeh.2012.05.005.CrossRefPubMedPubMedCentral

14.

Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56(7):617–26.CrossRef

15.

•• Wirrell EC, Bieber ED, Vanderwiel A, Kreps S, Weaver AL. Self-injurious and suicidal behavior in young adults, teens, and children with epilepsy: a population-based study. Epilepsia. 2020;61(9):1919–30. https://doi.org/10.1111/epi.16618This study found that children, teens, and young adults with a history of childhood epilepsy are at greater risk of self-injurious behavior.CrossRefPubMed

16.

Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72(2):184–91. https://doi.org/10.1002/ana.23601.CrossRefPubMed

17.

Hesdorffer DC, Ishihara L, Webb DJ, Mynepalli L, Galwey NW, Hauser WA. Occurrence and recurrence of attempted suicide among people with epilepsy. JAMA Psychiatry. 2016;73(1):80–6. https://doi.org/10.1001/jamapsychiatry.2015.2516.CrossRefPubMed

18.

Abraham N, Buvanaswari P, Rathakrishnan R, Tran BX, Thu GV, Nguyen LH, et al. A meta-analysis of the rates of suicide ideation, attempts and deaths in people with epilepsy. Int J Environ Res Public Health. 2019;16(8):1451. https://doi.org/10.3390/ijerph16081451.CrossRefPubMedCentral

19.

Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol. 2007;6(8):693–8. https://doi.org/10.1016/s1474-4422(07)70175-8.CrossRefPubMed

20.

Kim SJ, Kim HJ, Jeon JY, Kim HW, Lee SA. Clinical factors associated with suicide risk independent of depression in persons with epilepsy. Seizure. 2020;80:86–91. https://doi.org/10.1016/j.seizure.2020.05.026.CrossRefPubMed

21.

• Fontanella CA, Warner LA, Steelesmith D, Bridge JA, Sweeney HA, Campo JV. Clinical profiles and health services patterns of medicaid-enrolled youths who died by suicide. JAMA Pediatr. 2020;174(5):470–7. https://doi.org/10.1001/jamapediatrics.2020.0002This comparative study showed that there was no difference between sensitivity and specificity of the PHQ-9 versus the NDDI-E in patients with low ASM load; however, in patients with higher load, the PHQ-9 had poor specificity and the NDDI-E had poor sensitivity.CrossRefPubMed

22.

• Falcone T, Dagar A, Castilla-Puentes RC, Anand A, Brethenoux C, Valleta LG, et al. Digital conversations about suicide among teenagers and adults with epilepsy: a big-data, machine learning analysis. Epilepsia. 2020;61(5):951–8. https://doi.org/10.1111/epi.16507This first of its kind big data analysis used machine learning to find that teenagers engage in online conversation about suicide more than adults.CrossRefPubMedPubMedCentral

23.

Harnod T, Lin CL, Kao CH. Prevalence of suicide attempts and their risk factors in school-aged patients with epilepsy: a population-based study. Eur Child Adolesc Psychiatry. 2018;27(8):1047–53. https://doi.org/10.1007/s00787-018-1118-z.CrossRefPubMed

24.

Dagar A, Anand A, Pestana-Knight E, Timmons-Mitchell J, Tossone K, Zemba D, et al. Screening for suicidality and its relation to undiagnosed psychiatric comorbidities in children and youth with epilepsy. Epilepsy Behav. 2020;113:107443. https://doi.org/10.1016/j.yebeh.2020.107443.CrossRefPubMed

25.

• Nigussie K, Tesfaye B, Lemma A, Kerebih H. Magnitude and associated factors of suicidal ideation and attempt among people with epilepsy attending outpatient treatment at primary public hospitals in northwest Ethiopia: a multicentre cross-sectional study. BMJ Open. 2021;11(1):e043227. https://doi.org/10.1136/bmjopen-2020-043227This multicenter cross-sectional study of adults with epilepsy showed how psychosocial factors impact suicidality.CrossRefPubMedPubMedCentral

26.

Moreno A, Laoch A, Zasler ND. Changing the culture of neurodisability through language and sensitivity of providers: creating a safe place for LGBTQIA+ people. NeuroRehabilitation. 2017;41(2):375–93. https://doi.org/10.3233/nre-172187.CrossRefPubMed

27.

Johnson EL, Kaplan PW. Caring for transgender patients with epilepsy. Epilepsia. 2017;58(10):1667–72. https://doi.org/10.1111/epi.13864.CrossRefPubMed

28.

• Batchelor R, Taylor MD. Young adults with epilepsy: relationships between psychosocial variables and anxiety, depression, and suicidality. Epilepsy Behav. 2021;118:107911. https://doi.org/10.1016/j.yebeh.2021.107911This was a study of young adults with epilepsy that showed how coping and psychosocial factors impact mental health and suicidality in this group.CrossRefPubMed

29.

Lin M, Chen J, Li S, Qin Y, Wang X, Liu Y, et al. Risk factors for suicidal tendency in people with epilepsy in China: a case-control study. Sci Rep. 2021;11(1):2742. https://doi.org/10.1038/s41598-021-81870-9.CrossRefPubMedPubMedCentral

30.

Josephson CB, Jetté N. Psychiatric comorbidities in epilepsy. Int Rev Psychiatry. 2017;29(5):409–24. https://doi.org/10.1080/09540261.2017.1302412.CrossRefPubMed

31.

Erlangsen A, Stenager E, Conwell Y, Andersen PK, Hawton K, Benros ME, et al. Association between neurological disorders and death by suicide in Denmark. JAMA. 2020;323(5):444–54. https://doi.org/10.1001/jama.2019.21834.CrossRefPubMedPubMedCentral

32.

Jacob L, Oh H, Koyanagi A, Smith L, Kostev K. Relationship between physical conditions and attempted or completed suicide in more than 9,300 individuals from the United Kingdom: a case-control study. J Affect Disord. 2020;274:457–63. https://doi.org/10.1016/j.jad.2020.05.121.CrossRefPubMed

33.

•• Lu E, Pyatka N, Burant CJ, Sajatovic M. Systematic literature review of psychiatric comorbidities in adults with epilepsy. J Clin Neurol (Seoul, Korea). 2021;17(2):176–86. https://doi.org/10.3988/jcn.2021.17.2.176This review provided updates on psychiatric comorbidity prevalences among PWE.CrossRef

34.

Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48(12):2336–44. https://doi.org/10.1111/j.1528-1167.2007.01222.x.CrossRefPubMed

35.

Stefanidou M, Greenlaw C, Douglass LM. Mental health issues in transition-age adolescents and young adults with epilepsy. Semin Pediatr Neurol. 2020;36:100856. https://doi.org/10.1016/j.spen.2020.100856.CrossRefPubMed

36.

Lin CY, Harnod T, Lin CL, Shen WC, Kao CH. Differences in incidence and risks of suicide attempt and suicidal drug overdose between patients with epilepsy with and without comorbid depression. Int J Environ Res Public Health. 2019;16(22):4533. https://doi.org/10.3390/ijerph16224533.CrossRefPubMedCentral

37.

•• Sair A, Şair YB, Saracoğlu İ, Sevincok L, Akyol A. The relation of major depression, OCD, personality disorders and affective temperaments with temporal lobe epilepsy. Epilepsy Res. 2021;171:106565. https://doi.org/10.1016/j.eplepsyres.2021.106565These authors reviewed suicide-related behavior (SRB) before and after initiation of ASM therapy, and results suggested a strong possibility that the relationship between SRB and ASM is confounded by comorbidity.CrossRefPubMed

38.

Goodman WKPL, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989;46(11):1012–6.CrossRef

39.

Munger Clary HM, Snively BM, Hamberger MJ. Anxiety is common and independently associated with clinical features of epilepsy. Epilepsy Behav. 2018;85:64–71. https://doi.org/10.1016/j.yebeh.2018.05.024.CrossRefPubMedPubMedCentral

40.

Mbizvo GK, Bennett K, Simpson CR, Duncan SE, Chin RFM. Epilepsy-related and other causes of mortality in people with epilepsy: a systematic review of systematic reviews. Epilepsy Res. 2019;157:106192. https://doi.org/10.1016/j.eplepsyres.2019.106192.CrossRefPubMed

41.

(US-FDA). TUSFaDA. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Office of Translational Sciences Office of Biostatistics. Statistical Review and Evaluation of Antiepileptic Drugs and Suicidality. 2008. https://www.fda.gov/files/drugs/published/Statistical-Review-and-Evaluation--Antiepileptic-Drugs-and-Suicidality.pdf. Accessed 6/8/22.

42.

Raju Sagiraju HK, Wang CP, Amuan ME, Van Cott AC, Altalib HH, Pugh MJV. Antiepileptic drugs and suicide-related behavior: is it the drug or comorbidity? Neurol Clin Pract. 2018;8(4):331–9. https://doi.org/10.1212/cpj.0000000000000489.CrossRefPubMedPubMedCentral

43.

Caley CF, Perriello E, Golden J. Antiepileptic drugs and suicide-related outcomes in bipolar disorder: a descriptive review of published data. Mental Health Clin. 2018;8(3):138–47. https://doi.org/10.9740/mhc.2018.05.138.CrossRef

44.

Dreier JW, Pedersen CB, Gasse C, Christensen J. Antiepileptic drugs and suicide: role of prior suicidal behavior and parental psychiatric disorder. Ann Neurol. 2019;86(6):951–61. https://doi.org/10.1002/ana.25623.CrossRefPubMed

45.

Williams Roberson S, Rehman R, Bucurescu G. Antiepileptic drugs and suicidality in veterans with seizures. Neurology (ECronicon). 2019;11(12). https://www.ecronicon.com/ecne/pdf/ECNE-11-00610.pdf.

46.

Mula M, Sander JW. Suicide and epilepsy: do antiepileptic drugs increase the risk? Expert Opin Drug Saf. 2015;14(4):553–8. https://doi.org/10.1517/14740338.2015.1010506.CrossRefPubMed

47.

Chen B, Choi H, Hirsch LJ, Katz A, Legge A, Buchsbaum R, et al. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017;76:24–31. https://doi.org/10.1016/j.yebeh.2017.08.039.CrossRefPubMed

48.

Pompili M, Baldessarini RJ. Epilepsy: risk of suicidal behavior with antiepileptic drugs. Nat Rev Neurol. 2010;6(12):651–3. https://doi.org/10.1038/nrneurol.2010.165.CrossRefPubMed

49.

Pugh MJ, Hesdorffer D, Wang CP, Amuan ME, Tabares JV, Finley EP, et al. Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior. Neurology. 2013;81(22):1900–6. https://doi.org/10.1212/01.wnl.0000436614.51081.2e.CrossRefPubMedPubMedCentral

50.

Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163(1):41–7. https://doi.org/10.1176/appi.ajp.163.1.41.CrossRefPubMed

51.

Termorshuizen F, Palmen SJ, Heerdink ER. Suicide behavior before and after the start with antidepressants: a high persistent risk in the first month of treatment among the young. Int J Neuropsychopharmacol. 2015;19(2). https://doi.org/10.1093/ijnp/pyv081.

52.

Gudi SK, Jahan Q. Anti-seizure medications and risk of suicide: re-addressing the issue. Int J Clin Pract. 2021;75:e14194. https://doi.org/10.1111/ijcp.14194.CrossRefPubMed

53.

Fountoulakis KN, Gonda X, Samara M, Siapera M, Karavelas V, Ristic DI, et al. Antiepileptic drugs and suicidality. J Psychopharmacol (Oxford, England). 2012;26(11):1401–7. https://doi.org/10.1177/0269881112440514.CrossRef

54.

Ferrer P, Ballarín E, Sabaté M, Vidal X, Rottenkolber M, Amelio J, et al. Antiepileptic drugs and suicide: a systematic review of adverse effects. Neuroepidemiology. 2014;42(2):107–20. https://doi.org/10.1159/000356807.CrossRefPubMed

55.

•• Klein PDO, French J, Harden C, Krauss GL, McCarter R, Sperling MR. Suicidality risk of newer antiseizure medications: a meta-analysis. JAMA Neurol. 2021;78(9):1118–27 This study concluded that newer ASM does not increase suicide risk and, therefore, ASM do not warrant a class warning.CrossRef

56.

•• Gandy M, Modi AC, Wagner JL, LaFrance WC Jr, Reuber M, Tang V, et al. Managing depression and anxiety in people with epilepsy: a survey of epilepsy health professionals by the ILAE Psychology Task Force. Epilepsia Open. 2021;6(1):127–39. https://doi.org/10.1002/epi4.12455This survey of clinicians highlighted the incongruency between the well-known necessity of mental health care in PWE and the lack effective implementation.CrossRefPubMedPubMedCentral

57.

Amorim P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D. DSM-IH-R Psychotic disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry. 1998;13(1):26–34. https://doi.org/10.1016/s0924-9338(97)86748-x.CrossRefPubMed

58.

Hamilton M, Hamilton MA. Rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62.

59.

Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–44. https://doi.org/10.1001/jama.282.18.1737.CrossRefPubMed

60.

Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5(5):399–405. https://doi.org/10.1016/s1474-4422(06)70415-x.CrossRefPubMed

61.

Gill SJ, Lukmanji S, Fiest KM, Patten SB, Wiebe S, Jetté N. Depression screening tools in persons with epilepsy: a systematic review of validated tools. Epilepsia. 2017;58(5):695–705. https://doi.org/10.1111/epi.13651.CrossRefPubMed

62.

Rashid H, Katyal J, Sood M, Tripathi M. Depression in persons with epilepsy: a comparative study of different tools in Indian population. Epilepsy Behav. 2021;115:107633. https://doi.org/10.1016/j.yebeh.2020.107633.CrossRefPubMed

63.

Wagner JL, Kellermann T, Mueller M, Smith G, Brooks B, Arnett A, et al. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. Epilepsia. 2016;57(8):1265–70. https://doi.org/10.1111/epi.13446.CrossRefPubMed

64.

Elger CE, Johnston SA, Hoppe C. Diagnosing and treating depression in epilepsy. Seizure. 2017;44:184–93. https://doi.org/10.1016/j.seizure.2016.10.018.CrossRefPubMed

65.

Rampling J, Mitchell AJ, Von Oertzen T, Docker J, Jackson J, Cock H, et al. Screening for depression in epilepsy clinics. A comparison of conventional and visual-analog methods. Epilepsia. 2012;53(10):1713–21. https://doi.org/10.1111/j.1528-1167.2012.03571.x.CrossRefPubMed

66.

Kim HJ, Jeon JY, Kim HW, Lee SA. Comparison between the neurological disorders depression inventory for epilepsy and the Patient Health Questionnaire-9 in patients with epilepsy according to antiepileptic drug load. Seizure. 2020;74:14–9. https://doi.org/10.1016/j.seizure.2019.11.005.CrossRefPubMed

67.

Matijasevich A, Munhoz TN, Tavares BF, Barbosa AP, da Silva DM, Abitante MS, et al. Validation of the Edinburgh postnatal depression scale (EPDS) for screening of major depressive episode among adults from the general population. BMC Psychiatry. 2014;14:284. https://doi.org/10.1186/s12888-014-0284-x.CrossRefPubMedPubMedCentral

68.

Bumberry W, Oliver JM, McClure JN. Validation of the Beck Depression Inventory in a university population using psychiatric estimate as the criterion. J Consult Clin Psychol. 1978;46(1):150–5.CrossRef

69.

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9. https://doi.org/10.1192/bjp.134.4.382.CrossRefPubMed

70.

Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363–70. https://doi.org/10.1017/s0033291796004382.CrossRefPubMed

71.

Nathan Herrmann NM, Silver IL, Shulman KI, Busto UA, Shear NH, Naranjo CA. A validation study of The Geriatric Depression Scale short form. Int J Geriatr Psychiatry. 1996;11(5):457–60.CrossRef

72.

Jones JE, Hermann BP, Woodard JL, Barry JJ, Gilliam F, Kanner AM, et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia. 2005;46(5):731–5. https://doi.org/10.1111/j.1528-1167.2005.49704.x.CrossRefPubMed

73.

Le Fevre ML. Screening for suicide risk in adolescents, adults, and older adults in primary care: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(10):719–26. https://doi.org/10.7326/m14-0589.CrossRef

74.

• Li X, Ding S, Hua Y, Gong J, Dong F, Lin J, et al. Comparison of the performance of suicide ideation scales in adult patients with epilepsy in China. Epilepsy Behav. 2020;112:107405. https://doi.org/10.1016/j.yebeh.2020.107405This study of a population in southern China validated the SSI-C and SSI-W as good suicidal ideation screening tools and recommended the SSI-W, in particular, clinical use.CrossRefPubMed

75.

Posner K, Oquendo MA, Gould M, Stanley B, Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA’s pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164(7):1035–43. https://doi.org/10.1176/ajp.2007.164.7.1035.CrossRefPubMedPubMedCentral

76.

Mundt JC, Greist JH, Jefferson JW, Federico M, Mann JJ, Posner K. Prediction of suicidal behavior in clinical research by lifetime suicidal ideation and behavior ascertained by the electronic Columbia-Suicide Severity Rating Scale. J Clin Psychiatry. 2013;74(9):887–93. https://doi.org/10.4088/JCP.13m08398.CrossRefPubMed

77.

Greist JH, Mundt JC, Gwaltney CJ, Jefferson JW, Posner K. Predictive value of baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) assessments for identifying risk of prospective reports of suicidal behavior during research participation. Innov Clin Neurosci. 2014;11(9-10):23–31.PubMedPubMedCentral

78.

Hesdorffer DC, French JA, Posner K, DiVentura B, Pollard JR, Sperling MR, et al. Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia. 2013;54(5):879–87. https://doi.org/10.1111/epi.12128.CrossRefPubMed

79.

Mula M, McGonigal A, Micoulaud-Franchi JA, May TW, Labudda K, Brandt C. Validation of rapid suicidality screening in epilepsy using the NDDIE. Epilepsia. 2016;57(6):949–55. https://doi.org/10.1111/epi.13373.CrossRefPubMed

80.

Horowitz LM, Snyder DJ, Boudreaux ED, He JP, Harrington CJ, Cai J, et al. Validation of the ask suicide-screening questions for adult medical inpatients: a brief tool for all ages. Psychosomatics. 2020;61(6):713–22. https://doi.org/10.1016/j.psym.2020.04.008.CrossRefPubMed

81.

Dagar A, Falcone T. Psychiatric comorbidities in pediatric epilepsy. Curr Psychiatry Rep. 2020;22(12):77. https://doi.org/10.1007/s11920-020-01195-8.CrossRefPubMed

82.

Psychiatry TAAoCaA. American academy of child and adolescent psychiatry. Recommendations for pediatricians, family practitioners, psychiatrists, and non-physician mental health practitioners. 2022. https://www.aacap.org/aacap/Member_Resources/Practice_Information/When_to_Seek_Referral_or_Consultation_with_a_CAP.aspx. Accessed 6/8/22.

83.

Lopez MR, Schachter SC, Kanner AM. Psychiatric comorbidities go unrecognized in patients with epilepsy: “You see what you know”. Epilepsy Behav. 2019;98(Pt B):302–5. https://doi.org/10.1016/j.yebeh.2019.01.027.CrossRefPubMed

84.

Kerr MP, Mensah S, Besag F, de Toffol B, Ettinger A, Kanemoto K, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia. 2011;52(11):2133–8. https://doi.org/10.1111/j.1528-1167.2011.03276.x.CrossRefPubMed

85.

Patel AD, Baca C, Franklin G, Herman ST, Hughes I, Meunier L, et al. Quality improvement in neurology: epilepsy quality measurement set 2017 update. Neurology. 2018;91(18):829–36. https://doi.org/10.1212/wnl.0000000000006425.CrossRefPubMed

86.

Cotterman-Hart S. Depression in epilepsy: why aren't we treating? Epilepsy Behav. 2010;19(3):419–21. https://doi.org/10.1016/j.yebeh.2010.08.018.CrossRefPubMed

87.

Bermeo-Ovalle A. Psychiatric comorbidities go untreated in patients with epilepsy: ignorance or denial? Epilepsy Behav. 2019;98(Pt B):306–8. https://doi.org/10.1016/j.yebeh.2018.11.028.CrossRefPubMed

88.

Fiest KM, Patten SB, Altura KC, Bulloch AG, Maxwell CJ, Wiebe S, et al. Patterns and frequency of the treatment of depression in persons with epilepsy. Epilepsy Behav. 2014;39:59–64. https://doi.org/10.1016/j.yebeh.2014.08.023.CrossRefPubMed

89.

Blümcke I, Arzimanoglou A, Beniczky S, Wiebe S. Roadmap for a competency-based educational curriculum in epileptology: report of the epilepsy education task force of the International League Against Epilepsy. Epileptic Disord. 2019;21(2):129–40. https://doi.org/10.1684/epd.2019.1039.CrossRefPubMed

90.

•• Mental illness policy.org. Standards for involuntary commitment (Assisted Treatment) state-by-state (Source Treatment Advocacy Center). This curriculum includes management, treatment and referral for suicidality as key competencies for epileptologists. https://mentalillnesspolicy.org/national-studies/state-standards-involuntary-treatment.html. Accessed 6/8/22.

91.

Simon GE, Rutter CM, Peterson D, Oliver M, Whiteside U, Operskalski B, et al. Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death? Psychiatr Serv. 2013;64(12):1195–202. https://doi.org/10.1176/appi.ps.201200587.CrossRefPubMedPubMedCentral

92.

Micoulaud-Franchi JA, Bartolomei F, McGonigal A. Ultra-short screening instruments for major depressive episode and generalized anxiety disorder in epilepsy: the NDDIE-2 and the GAD-SI. J Affect Disord. 2017;210:237–40. https://doi.org/10.1016/j.jad.2016.12.038.CrossRefPubMed

93.

Munger Clary HM, Wan M, Conner K, Brenes GA, Kimball J, Kim E, et al. Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample. Epilepsy Behav : E&B. 2021;118:107943. https://doi.org/10.1016/j.yebeh.2021.107943.CrossRef

94.

Brenes GA, Danhauer SC, Lyles MF, Miller ME. Telephone-delivered psychotherapy for rural-dwelling older adults with generalized anxiety disorder: study protocol of a randomized controlled trial. BMC Psychiatry. 2014;14:34. https://doi.org/10.1186/1471-244X-14-34.CrossRefPubMedPubMedCentral

95.

Mula M, Sander JW. Psychosocial aspects of epilepsy: a wider approach. BJPsych Open. 2016;2(4):270–4. https://doi.org/10.1192/bjpo.bp.115.002345.CrossRefPubMedPubMedCentral

Titel: Suicide and Epilepsy
verfasst von: Luciana Giambarberi
Heidi M. Munger Clary
Publikationsdatum: 17.06.2022
Verlag: Springer US
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 8/2022
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-022-01206-6

Neurological Complications of Dengue Fever

Neurology of Systemic Diseases (J. Biller, Section Editor)

Treatment of Psychogenic Nonepileptic Seizures

Epilepsy (C. Elder, Section Editor)

The Neurology and Psychopathology of Pica

Neurology of Systemic Diseases (J. Biller, Section Editor)

Neurological Complications of Malaria

COVID-19
Neurology of Systemic Diseases (J. Biller, Section Editor)

Multiple Sclerosis Management During the COVID-19 Pandemic

COVID-19
Demyelinating Disorders (L. Wooliscroft and D. Bourdette, Section Editors)

Epilepsy Care in Transgender Patients

Epilepsy (C. Elder, Section Editor)

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

„Wir wollen die Bedeutung von Gen- und Umwelteinflüssen besser verstehen“

Bipolare Störung
Interview

Eine Mutation in einem einzelnen Gen kann bei Mäusen eine Art Bipolarstörung auslösen. PD Dr. Jan Deussing vom Max-Planck-Institut für Psychiatrie in München sieht in solchen Tiermodellen eine Möglichkeit, den Ursachen der Erkrankung auf den Grund zu gehen.

Suizidassistenz erhöht Suizidzahlen: Aktuelle Ergebnisse der geplanten S3-Leitlinie

DGPPN 2024
Kongressbericht

Erstmals wird in Deutschland eine S3-Leitlinie zum Thema Suizidalität erarbeitet. Ziel ist es, die Versorgung in suizidalen Krisen durch einheitliche Standards zu verbessern. Erste Ergebnisse der bisherigen Leitlinienarbeit wurden auf dem DGPPN-Kongress vorgestellt.

Kaum Vorteile durch intraarterielle Lyse während Thrombektomie

17.01.2025
Ischämischer Schlaganfall
Nachrichten

Nach der Thrombektomie kleinere Fragmente über eine intraarterielle Lyse auflösen – dies könnte die Schlaganfalltherapie verbessern. Zwei aktuelle Studien ergeben für die periprozedurale Lyse jedoch keine großen Vorteile. Die Frage, wie viel sie nützt, bleibt weiter offen.

Nasenstimulation lindert chronische Migräne

16.01.2025
Chronische Migräne
Nachrichten

Wird die Naseninnenseite durch Vibrationen stimuliert, kann dies offenbar die Zahl der Migränetage von Menschen mit chronischer Migräne deutlich senken. Darauf deuten die Resultate einer randomisiert-kontrollierten deutsch-finnischen Untersuchung.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Suicide and Epilepsy

Abstract

Purpose of Review

Recent Findings

Summary

Weitere Artikel der Ausgabe 8/2022

Neurological Complications of Dengue Fever

Treatment of Psychogenic Nonepileptic Seizures

The Neurology and Psychopathology of Pica

Neurological Complications of Malaria

Multiple Sclerosis Management During the COVID-19 Pandemic

Epilepsy Care in Transgender Patients

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Neu im Fachgebiet Neurologie

„Wir wollen die Bedeutung von Gen- und Umwelteinflüssen besser verstehen“

Suizidassistenz erhöht Suizidzahlen: Aktuelle Ergebnisse der geplanten S3-Leitlinie

Kaum Vorteile durch intraarterielle Lyse während Thrombektomie

Nasenstimulation lindert chronische Migräne

Update Neurologie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten